Lotte Kaasenbrood

Lotte Kaasenbrood

UNVERIFIED PROFILE

Are you Lotte Kaasenbrood?   Register this Author

Register author
Lotte Kaasenbrood

Lotte Kaasenbrood

Publications by authors named "Lotte Kaasenbrood"

Are you Lotte Kaasenbrood?   Register this Author

8Publications

133Reads

19Profile Views

Response by Kaasenbrood et al to Letter Regarding Article, "Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population".

Circulation 2017 03;135(13):e820-e821

From Department of Vascular Medicine (L.K., F.L.J.V.), Julius Centre for Health Sciences and Primary Care (Y.v.d.G.), University Medical Centre Utrecht, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.027317DOI Listing
March 2017

Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population.

Circulation 2016 Nov 28;134(19):1419-1429. Epub 2016 Sep 28.

From Department of Vascular Medicine (L.K., J.W., F.L.J.V.), Julius Centre for Health Sciences and Primary Care (Y.v.d.G.), Department of Cardiology (M.J.M.C.), Department of Neurology (L.J.K.), and Department of Vascular Surgery (G.J.d.B.), University Medical Centre Utrecht, the Netherlands; Departments of Cardiology (S.M.B., R.J.G.P.) and Vascular Medicine (J.J.P.K.), Academic Medical Centre, Amsterdam, the Netherlands; School of Public Health, Imperial College London, United Kingdom (K.K.R.); Department of Neurology and Stroke Center, Bichat University Hospital, Paris, France (P.A.); and SUNY Health Science Center at Brooklyn, New York, NY (J.C.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.021314DOI Listing
November 2016

Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study.

Circ Cardiovasc Qual Outcomes 2016 05 11;9(3):213-21. Epub 2016 May 11.

From the Department of Vascular Medicine (L.K., F.L.J.V.) and Julius Centre for Health Sciences and Primary Care (Y.v.d.G.), University Medical Centre Utrecht, Utrecht, The Netherlands; ICCH, Imperial College London, London, United Kingdom (N.R.P., P.S.S.); Biomedical Research Institute, University of Dundee, Dundee, Scotland, United Kingdom (H.M.C., S.J.L.); Department of Cardiology, Academic Medical Centre, Amsterdam, The Netherlands (S.M.B.); and University of Texas Health Science Center, Houston (S.L.P., B.R.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.115.001980DOI Listing
May 2016

How to translate clinical trial results into gain in healthy life expectancy for individual patients.

BMJ 2016 Mar 30;352:i1548. Epub 2016 Mar 30.

Harvard Medical School, Boston, MA, USA; Centre for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.i1548DOI Listing
March 2016

[Acute liver injury in a patient with anorexia nervosa].

Ned Tijdschr Geneeskd 2013 ;157(29):A6247

St. Antonius Ziekenhuis, Afd. Interne Geneeskunde, Nieuwegein, the Netherlands.

View Article

Download full-text PDF

Source
November 2013

Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus.

Diabetes Technol Ther 2012 Dec 31;14(12):1134-9. Epub 2012 Oct 31.

Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/dia.2012.0120DOI Listing
December 2012